Traumatic brain injury (TBI) is common among military veterans and has been associated with an increased risk of dementia. Whether this is due to an i..
More than 70% of patients with traumatic brain injury (TBI) reported at least one problematic symptom at one year of follow-up that was new or worse than before injury.
Development of New Tools to Fight SARS-CoV-2
Sponsored Content by ACROBiosystemsMar 2 2021
A novel coronavirus hit the human population in December 2019, causing a worldwide pandemic from which we are still recovering. Although vaccines seem initially successful, it is still important to develop new approaches and tools to combat the evolving SARS-CoV-2 contagion.
The recent collaboration established by Professor Michael Wallach, Director of the Centre for Innovative Medical Research and professor at the University of Technology, Sydney, Australia, is one team currently being supported by ACROBiosystems to help find novel ways to protect people from SARS-CoV-2 infective attacks.
Professor Wallach is the Director of SPARK Oceania, part of the SPARK global consortium, an organization that promotes medical research that benefits patients through a mentoring and support program for aspiring researchers, innovative ideas, and seed funding.
Promising nanobodies against COVID-19 produced by llamas
Thought LeadersDr. David BrodyProfessor of NeurologyUniformed Services University
In this interview, News-Medical speaks to Dr. David Brody about his latest research that involved discovering nanobodies produced by llamas that could help combat coronavirus.
What provoked your research into the ongoing COVID-19 pandemic?
We are neuroscientists, so it was a bit of a shift in direction! For several years TJ and I had been testing out how to use nanobodies to make brain imaging better. When the pandemic broke, we thought this is a once in a lifetime, all-hands-deck situation and joined the fight.
Jan 20 2021 Read 13516 Times
In a novel twist for COVID-19 research, a team of neuroscientists from the NIH/National Institute of Neurological Disorders and Stroke has uncovered data suggesting llama antibodies could be used to prevent and diagnose human infections. The team managed to isolate tiny nanobodies’ produced by a laboratory llama named Cormac, with preliminary results suggesting a particular single-domain fragment known as NIH-CoVnb-112 could be used to latch onto SARS-CoV-2 spike proteins and prevent infection.
From brain imaging to epidemiology
Findings were published in the journal Scientific Reports, with senior author David L. Brody saying the study is an exciting step forward for COVID-19 research. “For years TJ and I had been testing out how to use nanobodies to improve brain imaging. When the pandemic broke, we thought this was a once in a lifetime, all-hands-on-deck situation and joined the fight, says Brody. We hope that these anti-COVID-19 nanobodi